This special report covers The Dhaka Declaration, an initiative of the five-nation South Asian Federation of Endocrine Societies (SAFES). Involving Bangladesh, India, Nepal, Pakistan, and Sri Lanka, this endocrine association aims to bring gestational diabetes mellitus (GDM) to the center stage of clinical medicine as well as public health. The Dhaka Declaration provides guidance for advocacy, research, and guideline formation in the field of GDM. Through these activities, SAFES hopes to bring about universal screening, uniformity in diagnosis, optimal management, and regular follow-up of GDM.
South Asia-Diabetes Capital
South Asia is known as the Diabetes Capital of the World, and justifiably so. Home to three of the world's largest populations of people living with diabetes (India, Bangladesh, and Pakistan), it also includes nations with an equally high prevalence of diabetes (Bhutan, Maldives, Nepal, and Sri Lanka). With diabetes having entrenched itself in the South Asian populace, it is now considered an endemic, rather than an epidemic. 
Gestational Diabetes Mellitus
Epidemics of disease usually require interventions that are designed to show rapid control that may be short term. Endemics, on the other hand, need long-term measures that help contain the illness and lead to longlasting benefit as well. The Dhaka Declaration-From Thoughts to Words GDM was chosen because of its public health importance, 3 the opportunity it provides for interspecialty and interprofessional collaboration, and the availability of evidence-backed nonpharmacologic and pharmacologic interventions that can favorably impact health-related outcomes. 4 Most importantly, GDM was identified to have a transgenerational influence on health, affecting not only the woman with GDM, during and after pregnancy, but also the offspring, in utero, in infancy, and later in adult life as well.
The Dhaka Declaration lists various aims and describes the activities to be conducted across all South Asian countries. In the declaration, SAFES resolves to facilitate universal screening, uniformity in diagnosis, and optimal management and follow-up of GDM, including appropriate usage of insulin. It also proposes indicators or markers to assess progress in this field.
From Words to Action
Six months after the Dhaka Declaration was released, SAFES met again screening. Studies will also be conducted to assess current practice related to GDM management across South Asia. The Guideline Writing Taskforce will encapsulate available evidence to prepare pragmatic suggestions.
Guidelines of international quality, appropriate to the South Asian population and health care system, will be drafted and published. Current practice trends among South Asian physicians will be assessed by means of a questionnaire. Public education targeting schools and colleges with education material and talks on noncommunicable disease, with GDM as the fulcrum, will be supported.
South Asia-The Diabetes Care Capital
The Dhaka Declaration, building upon earlier multinational South Asian initiatives, 5 has created an optimistic atmosphere of proactive collaboration in South Asia endocrinology circles. With various activities planned, more and more clinicians, researchers, and policymakers are being involved in the management and follow-up of GDM. Through successful implementation of The Dhaka Declaration, SAFES hopes to improve the quality of care provided to women with GDM, improve diabetes care in general, and help contain the diabetes endemic.
The Dhaka Declaration is a means to focus our collective energy and strength, to create synergy and teamwork, and to achieve a common goal:
to ensure that South Asia gets recognized not as the diabetes capital, but as the diabetes CARE capital, of the world. n
